AC Immune SA and collaborators including National Institute on Aging, Alzheimer’s Disease Cooperative Study (ADCS) and LuMind Research Down Syndrome Foundation led by USC Keck School of Medicine conducted a clinical trial on an Alzheimer’s vaccine tested on Down...
United Neuroscience (UNS), a clinical-stage biotech company pioneering a new class of medicine to treat and prevent brain disorders, today announced positive top-line results from its Phase 2a clinical study of UB-311, a novel synthetic peptide vaccine targeting beta...
A DNA vaccine developed at the University of Texas and tested on mice could represent a future treatment for Alzheimer’s disease and may soon be incorporated into human clinical trials. The experimental vaccine reduced the accumulation of two classes of toxic proteins...
Pin It on Pinterest
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site you consent to our use of cookies.Ok
